Google ’ s Masterplan for Healthcare

With 7% of Google searches – or 70,000 per minute – being health-related, it was only a matter of time before the search giant aimed to be a healthcare giant. Google hasn’t been particularly shy at expressing these ambitions either. It purchased Fitbit for $2.1 billion and had a dedicated healthcare offshoot from its A.I. branch, Deepmind. In this new article series exploring the latest moves by tech giants into healthcare, we will look at recent developments coming from Google. Previous entries looked at the moves of Google’s competitors Amazon and Apple, and provided insights into the trends that those companies are adopting. For now, let’s turn our focus on Google’s plan for the future of healthcare. Of note, we will treat Google, Alphabet and Verily under the same umbrella. Alphabet is itself the parent company of Google, and Verily is a subsidiary of Alphabet that focuses on human health. Google in healthcare Verily, Calico, Deepmind, more than 150 patents in life sciences and countless collaborations with pharma companies. The search engine’s parent company, Alphabet takes its move into healthcare and medicine seriously. Alphabet’s venture arm,  GV (formerly known as Google Ventures) is investing heavily in companies in life sciences. Their portfolio is very diverse ranging from genetics to telemedicine. 23andme, the most well-known direct-to-consumer genetic testing company with one of the biggest DNA databases in the world. Oscar Health, the New ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Artificial Intelligence in Medicine Digital Health Research Future of Medicine Future of Pharma Genomics Health Sensors & Trackers Portable Medical Diagnostics Security & Privacy AI genetics google Healthcare Innovation technolog Source Type: blogs